These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6429282)

  • 1. Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
    Nielsen JA; Moore KE
    J Neurochem; 1984 Aug; 43(2):593-6. PubMed ID: 6429282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
    Yarbrough GG
    Eur J Pharmacol; 1978 Mar; 48(1):19-27. PubMed ID: 416961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the TRH analog L-pyro-2-aminoadipyl-L-histidyl-[3H]-L-thiazolidine-4-carboxamide (MK-771) in gut and brain tissue of rats: the implications for its bioavailability.
    Vickers S; Duncan CA; Arison BH; Ramjit HG; Rosegay A; Nutt RF; Veber DF
    Drug Metab Dispos; 1983; 11(2):147-51. PubMed ID: 6133720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MK-771 on the isolated amphibian spinal cord: comparison with thyrotropin-releasing hormone.
    Yarbrough GG; Singh DK
    Can J Physiol Pharmacol; 1979 Aug; 57(8):920-2. PubMed ID: 115561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury.
    Tanaka K; Ogawa N; Asanuma M; Kondo Y
    Regul Pept; 1997 Jun; 70(2-3):173-8. PubMed ID: 9272630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro.
    Deshpande SB; Warnick JE
    Eur J Pharmacol; 1994 Dec; 271(2-3):439-44. PubMed ID: 7705444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice.
    Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N
    Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging blocks the thermoregulatory action of thyrotropin-releasing hormone in anaesthetized rats.
    Amir S
    Brain Res; 1988 Feb; 440(1):181-4. PubMed ID: 3129125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thyrotropin-releasing hormone analogues on body shaking and prolactin levels in estrogen-primed and nonprimed rats.
    Yamada K; Kumagai M; Nagashima M; Matsuo N; Furukawa T
    Arch Int Pharmacodyn Ther; 1989; 297():235-46. PubMed ID: 2499289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance.
    Simasko SM; Horita A
    Neuropharmacology; 1985 Feb; 24(2):157-65. PubMed ID: 2986033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum.
    Das S; Bhargava HN
    Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
    Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
    Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyrotropin-releasing hormone (TRH) and a TRH analogue, MK-771, on punished responding of squirrel monkeys.
    Brady LS; Valentine JO; Barrett JE
    Psychopharmacology (Berl); 1984; 83(2):151-4. PubMed ID: 6431464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effect of intravenously administered thyrotropin-releasing hormone and its concentration in push-pull perfusion of the fourth ventricle in conscious and pentobarbital-anesthetized rats.
    Okuda C; Tanaka H; Miyazaki M
    Life Sci; 1988; 42(11):1181-8. PubMed ID: 3126373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    J Neurochem; 1982 Jul; 39(1):235-8. PubMed ID: 6177832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.